Clorox Management
Management criteria checks 4/4
Clorox's CEO is Linda Rendle, appointed in Sep 2020, has a tenure of 4.25 years. total yearly compensation is $12.69M, comprised of 9.6% salary and 90.4% bonuses, including company stock and options. directly owns 0.02% of the company’s shares, worth $4.03M. The average tenure of the management team and the board of directors is 4.3 years and 6.3 years respectively.
Key information
Linda Rendle
Chief executive officer
US$12.7m
Total compensation
CEO salary percentage | 9.6% |
CEO tenure | 4.3yrs |
CEO ownership | 0.02% |
Management average tenure | 4.3yrs |
Board average tenure | 6.3yrs |
Recent management updates
Recent updates
Return Trends At Clorox (NYSE:CLX) Aren't Appealing
Dec 02The Clorox Company: Hold, Trading Above Fair Value Despite Positive Signals
Nov 26Increases to CEO Compensation Might Be Put On Hold For Now at The Clorox Company (NYSE:CLX)
Nov 14An Intrinsic Calculation For The Clorox Company (NYSE:CLX) Suggests It's 40% Undervalued
Oct 07Why We're Not Concerned About The Clorox Company's (NYSE:CLX) Share Price
Sep 21Clorox: If You Need FMCG Player In A Portfolio - Look Elsewhere
Sep 15Clorox (NYSE:CLX) Will Pay A Larger Dividend Than Last Year At $1.22
Aug 03Here's What To Make Of Clorox's (NYSE:CLX) Decelerating Rates Of Return
Jul 29Clorox: Stellar Delivery But Valuation Compression Has Some Distance To Go
Jul 29Clorox: Questionable Growth Target Puts Me On The Sidelines
Jul 17Clorox: Improving Outlook, Good Dividend Yield And Discounted Valuation
Jun 28Is Clorox (NYSE:CLX) A Risky Investment?
May 25We Like The Quality Of Clorox's (NYSE:CLX) Earnings
May 07Clorox (NYSE:CLX) Could Be At Risk Of Shrinking As A Company
Apr 26Colgate-Palmolive: Improved Financials To Navigate Headwinds (Rating Upgrade)
Apr 21Is There An Opportunity With The Clorox Company's (NYSE:CLX) 31% Undervaluation?
Apr 10Is Clorox (NYSE:CLX) Using Too Much Debt?
Feb 09Clorox: Relatively Overvalued And Headwinds Put Dividend At Risk
Feb 08The Clorox Company's (NYSE:CLX) Popularity With Investors Is Under Threat From Overpricing
Jan 25Is The Clorox Company (NYSE:CLX) Trading At A 27% Discount?
Jan 07Clorox: Not Wiped Out By Cyber Attack, Earnings And Revenue Need Cleaning Up
Jan 03Clorox: One Of The Best Household Product Portfolios
Dec 01Clorox: Undervalued But Too Many Red Flags
Oct 28Clorox: Cyberattack Compounds Existing Challenges
Oct 10Clorox: Still Struggling
Sep 25The Clorox Company: The Necessary Clean-Up Has Only Begun
Aug 30Despite Earnings Rally, Expectations On Clorox Are Low
Aug 15Clorox: Stable Growth Prospects But Pricey
Jul 20Keeping My Portfolio Clean By Avoiding Clorox
Jul 06Colgate-Palmolive: Stagnation And Debt-Fueled Dividends
Jun 01Clorox: Finally Emerging From The Pandemic Shadows
Feb 21Clorox declares $1.18 dividend
Feb 15CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | US$357m |
Jun 30 2024 | US$13m | US$1m | US$280m |
Mar 31 2024 | n/a | n/a | US$240m |
Dec 31 2023 | n/a | n/a | US$80m |
Sep 30 2023 | n/a | n/a | US$86m |
Jun 30 2023 | US$12m | US$1m | US$149m |
Mar 31 2023 | n/a | n/a | US$74m |
Dec 31 2022 | n/a | n/a | US$435m |
Sep 30 2022 | n/a | n/a | US$405m |
Jun 30 2022 | US$9m | US$1m | US$462m |
Mar 31 2022 | n/a | n/a | US$458m |
Dec 31 2021 | n/a | n/a | US$247m |
Sep 30 2021 | n/a | n/a | US$437m |
Jun 30 2021 | US$8m | US$1m | US$710m |
Mar 31 2021 | n/a | n/a | US$923m |
Dec 31 2020 | n/a | n/a | US$1b |
Sep 30 2020 | n/a | n/a | US$1b |
Jun 30 2020 | US$2m | US$524k | US$939m |
Mar 31 2020 | n/a | n/a | US$870m |
Dec 31 2019 | n/a | n/a | US$816m |
Sep 30 2019 | n/a | n/a | US$813m |
Jun 30 2019 | US$2m | US$436k | US$820m |
Mar 31 2019 | n/a | n/a | US$796m |
Dec 31 2018 | n/a | n/a | US$790m |
Sep 30 2018 | n/a | n/a | US$841m |
Jun 30 2018 | US$2m | US$436k | US$823m |
Compensation vs Market: Linda's total compensation ($USD12.69M) is about average for companies of similar size in the US market ($USD12.88M).
Compensation vs Earnings: Linda's compensation has been consistent with company performance over the past year.
CEO
Linda Rendle (46 yo)
4.3yrs
Tenure
US$12,685,308
Compensation
Ms. Linda Rendle serves as Chief Executive Officer and Director of The Clorox Company since September 14 2020 & serves as January 1, 2024. Ms. Rendle served as President of The Clorox Company from May 4, 2...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Chairman | 4.3yrs | US$12.69m | 0.020% $ 4.0m | |
Executive VP & CFO | 6.7yrs | US$4.32m | 0.043% $ 8.7m | |
Executive VP and Chief Operating & Strategy Officer | 4.3yrs | US$4.77m | 0.044% $ 8.9m | |
Executive VP | 19.4yrs | US$3.45m | 0.0077% $ 1.6m | |
Executive VP and Chief People & Corporate Affairs Officer | 8.8yrs | US$3.54m | 0.019% $ 3.9m | |
VP, Chief Accounting Officer & Corporate Controller | 3.6yrs | no data | 0.0019% $ 386.7k | |
Senior VP and Chief Information & Data Officer | 4.5yrs | no data | no data | |
Vice President of Investor Relations | no data | no data | no data | |
Senior VP & Chief Marketing Officer | 2.8yrs | no data | no data | |
Chief Diversity Officer | 18.5yrs | no data | no data | |
Executive VP and Executive Chief of Staff | 2.8yrs | US$3.56m | 0.0084% $ 1.7m | |
Executive VP and Group President of Health & Hygiene | 3.3yrs | no data | 0.0081% $ 1.7m |
4.3yrs
Average Tenure
52yo
Average Age
Experienced Management: CLX's management team is considered experienced (4.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Chairman | 4.3yrs | US$12.69m | 0.020% $ 4.0m | |
Independent Director | 9.4yrs | US$287.50k | 0.0010% $ 213.7k | |
Independent Director | 8.3yrs | US$267.50k | 0.00048% $ 97.7k | |
Independent Director | 9.4yrs | US$292.50k | 0.00052% $ 105.8k | |
Independent Director | 11.3yrs | US$282.50k | no data | |
Lead Independent Director | 6.3yrs | US$405.00k | no data | |
Independent Director | 7.8yrs | US$267.50k | no data | |
Independent Director | less than a year | no data | 0.0040% $ 822.3k | |
Independent Director | less than a year | no data | no data | |
Independent Director | 2.6yrs | US$267.50k | no data | |
Independent Director | 2.6yrs | US$267.50k | no data |
6.3yrs
Average Tenure
60yo
Average Age
Experienced Board: CLX's board of directors are considered experienced (6.3 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 01:46 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
The Clorox Company is covered by 43 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
John Staszak | Argus Research Company |
Edward Lewis | Atlantic Equities LLP |
Ishan Majumdar | Baptista Research |